See also this year's filing and all EDGAR filings for this company.
PDF Report 0000315545_2013_Provectus_Biopharmaceuticals_INC.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0000315545, Provectus Biopharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 0 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 4,925,948 |
| 2 | PropertyPlantAndEquipmentNet | 29,829 |
| 3 | remainder_Assets | 1,248,701 |
| 4 | LiabilitiesCurrent | 511,424 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 1,299,570 |
| 7 | CostOfGoodsAndServicesSold | 15,216 |
| 8 | SellingGeneralAndAdministrativeExpense | 66,185,889 |
| 9 | ResearchAndDevelopmentExpense | 43,098,853 |
| 10 | remainder_Expenses | 6,789,497 |
| 11 | remainder_Revenues | 39,757 |
| 12 | remainder_NetIncome | -2,303,378 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 6,204,478 |
| 1 | Liabilities | 1,810,994 |
| 2 | Expenses | 116,089,455 |
| 3 | Revenues | 39,757 |
| 4 | StockholdersEquity | 4,393,484 |
| 5 | NetIncome | -118,353,076 |
| 6 | ComprehensiveNetIncome | -118,353,076 |
| 7 | BaseVar | 63,224,031 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -27.1 |
| 9 | EconomicCapitalRatio | 0.0000000000000000000000000359 |
Edgar->Model Mapping
Feature Distribution
Change over Time
